Social News XYZ     

New studies on Eli Lilly’s obesity drug tirzepatide show promising results, company says (Video)

Pharmaceutical giant Eli Lilly is requesting fast-track approval from the Food and Drug Administration for its Type 2 diabetes medication tirzepatide to be sold as a weight loss drug. The company said that new studies have shown promising results. Nikki Battiste has more.

"CBS Evening News with Norah O'Donnell" delivers the latest news and original reporting, and goes beyond the headlines with context and depth. Catch the "CBS Evening News" weeknights at 6:30 p.m. ET on the CBS Television Network and at 10 p.m. ET on the CBS News app.

Subscribe to the "CBS Evening News" YouTube channel: https://bit.ly/1S7Dhik
Watch full episodes of "CBS Evening News": https://cbsn.ws/23XekKA
Follow "CBS Evening News" on Instagram: https://bit.ly/1T8icTO
Like "CBS Evening News" on Facebook: https://on.fb.me/1KxYobb
Follow "CBS Evening News" on Twitter: https://bit.ly/1O3dTTe
Download the CBS News app: https://cbsn.ws/1Xb1WC8
Try Paramount+ free: https://bit.ly/2OiW1kZ

 

For video licensing inquiries, contact: licensing@veritone.com

New studies on Eli Lilly's obesity drug tirzepatide show promising results, company says (Video)

Facebook Comments
New studies on Eli Lilly's obesity drug tirzepatide show promising results, company says (Video)

About SocialNewsXYZ

An Indo-American News website. It covers Gossips, Politics, Movies, Technolgy, and Sports News and Photo Galleries and Live Coverage of Events via Youtube. The website is established in 2015 and is owned by AGK FIRE INC.

Summary
New studies on Eli Lilly's obesity drug tirzepatide show promising results, company says (Video)
Title
New studies on Eli Lilly's obesity drug tirzepatide show promising results, company says (Video)
Description

Pharmaceutical giant Eli Lilly is requesting fast-track approval from the Food and Drug Administration for its Type 2 diabetes medication tirzepatide to be sold as a weight loss drug. The company said that new studies have shown promising results. Nikki Battiste has more. "CBS Evening News with Norah O'Donnell" delivers the latest news and original reporting, and goes beyond the headlines with context and depth. Catch the "CBS Evening News" weeknights at 6:30 p.m. ET on the CBS Television Network and at 10 p.m. ET on the CBS News app. Subscribe to the "CBS Evening News" YouTube channel: https://bit.ly/1S7Dhik Watch full episodes of "CBS Evening News": https://cbsn.ws/23XekKA Follow "CBS Evening News" on Instagram: https://bit.ly/1T8icTO Like "CBS Evening News" on Facebook: https://on.fb.me/1KxYobb Follow "CBS Evening News" on Twitter: https://bit.ly/1O3dTTe Download the CBS News app: https://cbsn.ws/1Xb1WC8 Try Paramount+ free: https://bit.ly/2OiW1kZ For video licensing inquiries, contact: licensing@veritone.com